Stocks
20/20 Biolabs, Inc.AIDX
NASDAQServicesBiotechnology$0.24
Price as of · delayed, not real-time
A specialty biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its lead product candidate targets a significant unmet medical need in the neurology space, with ongoing clinical trials that investors monitor for data readouts and regulatory milestones.
52W Range: $0.24-$50.00
Congressional Interest in 20/20 Biolabs, Inc. (AIDX)
No congressional trades have been disclosed for 20/20 Biolabs, Inc. (AIDX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading AIDX?
No congressional trades found for this stock.